Stocklytics Platform
Asset logo for symbol XBIT
XBiotech
XBIT66
$6.52arrow_drop_up4.15%$0.26
Asset logo for symbol XBIT
XBIT66

$6.52

arrow_drop_up4.15%

Income Statement (XBIT)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT-$14.96M-$10.85M-$8.19M-$7.45M-$14.27M
EBITDA-$14.53M-$10.42M-$8.15M-$7.02M-$14.15M
gross Profit-$435.00K-$432.00K$2.18M-$432.00K-$435.00K
NET Income-$13.00M-$10.00M-$4.63M-$7.36M-$8.74M
total Revenue$0.00$2.62M$2.62M$0.00$0.00

Balance Sheet (XBIT)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents-----
net Debt-$178.53M-$191.03M-$200.02M-$202.19M-$143.39M
stockholders Equity$196.70M$209.28M$218.84M$222.65M$229.06M
total Assets$215.55M$227.85M$227.24M$229.59M$235.13M
total Debt$10.00M$10.00M---
total Liabilities$18.85M$18.57M$8.39M$6.94M$6.07M

Cash Flow (XBIT)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow$48.00K$10.05M-$9.22M$5,000.00$9.20M
free Cash Flow-$12.00M-$7.45M-$3.54M-$1.52M-$9.20M
investing Cash Flow-----$208.00K
operating Cash Flow-$11.37M-$7.20M-$3.43M-$1.48M-$8.99M

XBiotech (XBIT) Financials

XBiotech Inc (XBIT) is a biotechnology company specializing in the development and commercialization of antibody therapies for treating diseases. The company's financials provide insight into its performance and financial health. The income statement reveals the company's revenue, expenses, and net income. XBiotech Inc's total revenue indicates the amount of money generated from its products and services. The gross profit represents the revenue minus the cost of goods sold, providing an indication of the company's profitability.
The company's net income from stockholders reflects the earnings that are distributed to its shareholders after deducting expenses and taxes. The balance sheet provides an overview of the company's assets, liabilities, and stockholders' equity. XBiotech Inc's total assets include cash, investments, property, and intellectual property rights. The total debt and liabilities represent the company's obligations, such as loans, leases, and payables.
Cash equivalents refer to highly liquid assets that can be easily converted into cash within a short time frame. XBiotech Inc's net debt reflects its total debt minus its cash and cash equivalents. Stockholders' equity represents the ownership interest of the company's shareholders, calculated as the difference between assets and liabilities. The cash flow statement details the company's cash inflows and outflows from various activities.
The financing cash flow section shows the cash generated or used from activities like issuing or repurchasing stock and paying dividends. The investing cash flow section indicates the cash flow from activities such as purchasing or selling long-term assets. The operating cash flow section provides insight into the company's cash generated or used in its day-to-day operations. XBiotech Inc's free cash flow represents the cash remaining after deducting capital expenditures from operating cash flow.
XBiotech Inc's financials, including income statement, balance sheet, and cash flow statement, are essential tools for investors and analysts to evaluate the company's financial performance and make informed investment decisions. Understanding these financial metrics helps assess the company's profitability, liquidity, leverage, and overall financial health.
add XBiotech  to watchlist

Keep an eye on XBiotech

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media